LITTLE ROCK, Ark., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Uniti Wholesale today announced accelerated progress on its 2026 expansion plan, including new data center on-ramps, key route upgrades, and the launch of FastWaves™—a pre-deployed optical capacity program designed to cut delivery intervals for 100G and 400G wavelength services to less than three weeks on select routes. These initiatives expand the company’s reach to critical U.S. data centers while pairing faster turn-ups with market-aligned pricing and ...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES Vancouver, BC, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Trident Resources Corp. (TSX-V: ROCK) (OTCQB: TRDTF) (“Trident” or the “Company”) is pleased to announce that it has closed its previously announced private placements (please refer to the Company’s January 27th, 2026, and February 2nd, 2026 news releases). A total of 4,948,000 common shares of the Company that qualify as “flow-through shares” within the meaning of subsection ...

18 February 2026 LSE Code: 3HCS WISDOMTREE MULTI ASSET ISSUER PUBLIC LIMITED COMPANY(a public company incorporated with limited liability in Ireland)WISDOMTREE COPPER 3X DAILY SHORT SECURITIES ISIN: IE00B8KD3F05 RESULTS OF MEETING OF THE ETP SECURITYHOLDERS WisdomTree Multi Asset Issuer Public Limited Company (the “Issuer”) wishes to announce that the Extraordinary Resolution regarding the reduction in the principal amount of the WisdomTree Copper 3x Daily Short Securities (the “Affected Securities”) from U ...

Agreement Initiates Data-Driven Technical Due Diligence of an Operational, Utility-Scale Solar Asset in IsraelTEL AVIV, Israel, Feb. 18, 2026 (GLOBE NEWSWIRE) -- PRF Technologies Ltd. (Nasdaq: PRFX) (“PRF” or the “Company”) (formerly “PainReform”) today announced that its DeepSolar business unit has entered into a solar analytics services agreement with a subsidiary of EDF Group (Electricite’ De France, France’s Electric Company, one of the largest international energy companies), a global leader in renewab ...

Core Insights - Prenetics Global Limited achieved record financial results in 2025, driven by the strong performance of its IM8 brand, marking a transformational year for the company [2][3][28] Financial Performance - Full-year revenue surged approximately 480% year-over-year to $92.4 million, with fourth quarter revenue reaching $36.6 million, a 55% increase quarter-over-quarter [3][41] - IM8 contributed $60.1 million in revenue for FY2025 and achieved an annualized recurring revenue (ARR) of approximately $120 million within just 12 months of launch [3][28] - Adjusted EBITDA loss improved by 27.2% year-over-year to $(13.0) million for FY2025, reflecting the capital efficiency of the IM8 business model [43][40] Strategic Actions - The company divested ACT Genomics for up to $72 million, sold the Europa distribution business for up to $13 million, and sold its stake in Insighta to Tencent for $70 million, enhancing its balance sheet to approximately $171 million in total adjusted liquidity [2][27][31] - The strategic transformation focused on streamlining operations and positioning IM8 as the core growth engine, resulting in a simplified operating structure [2][24][26] IM8 Brand Growth - IM8 was the primary growth driver, achieving a monthly revenue of $10 million in December 2025, with a 51% growth from Q3 to Q4 [4][3] - The brand's global reach expanded significantly, with over 60% of revenue generated outside the United States, indicating strong international demand [13][12] Customer Metrics - The total customer orders exceeded 230,000 in Q4 2025, with a 35% increase from Q3 [7] - The average order value increased to $133 in Q4 2025, reflecting a 31% growth from the previous quarter [7][18] Future Outlook - The company expects to triple IM8 revenue in 2026, targeting $180 million to $200 million, with a path towards $250 million to $300 million in ARR by the end of 2026 [30][32] - The transition to quarterly subscription plans is anticipated to enhance cash flow and customer lifetime value, with new blended average order values reaching approximately $233 in early 2026 [15][29]

Partnership gives independent agencies access to Audience Intelligence tools designed to sharpen targeting and close the data gap with holding company competitors Boca Raton, FL, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Bright Mountain Media, Inc. (OTCQB: BMTM) ("Bright Mountain" or the "Company"), a marketing services platform, today announced that Big Village has become a Preferred Data and Insights Partner within Indie Agency News' newly launched Preferred Partner Program. Independent agencies are under increas ...

Core Insights - Sealing Technologies (SealingTech), a subsidiary of Parsons Corporation, has received an Intent to Award notification from the United States Cyber Command for a sole-source contract to produce the Joint Cyber Hunt Kit solution, with a potential value of up to $500 million over three years [1][2]. Group 1: Company Developments - The contract marks a significant step in SealingTech's collaboration with the Department of War's Defense Innovation Unit and USCYBERCOM, focusing on advanced defensive cyber technologies [2]. - Parsons acquired SealingTech in 2023 to enhance its cyber operations capabilities for the Defense and Intelligence sectors, aiming to solidify its leadership in national security [2][3]. - SealingTech has a decade-long history of supporting the U.S. Department of War, having deployed over 500 Cyber Fly-Away Kits for critical national security missions [3]. Group 2: Strategic Vision - Parsons emphasizes its commitment to providing mission-ready solutions that ensure the U.S. military's operational superiority [3]. - The collaboration with DIU and USCYBERCOM aims to advance next-generation defensive cyber capabilities, enhancing the tactical advantage of warfighters [4]. - Parsons integrates various cyber capabilities, including offensive and defensive operations, to deliver transformative solutions that support multi-domain operations [4].

Core Insights - Akari Therapeutics is set to present at the 2026 Biocom Global Partnering & Investor Conference, highlighting its focus on oncology biotechnology and antibody drug conjugates (ADCs) with novel immuno-oncology payloads [1][2]. Company Overview - Akari Therapeutics specializes in developing next-generation ADCs, particularly focusing on a unique payload, PH1, which targets RNA splicing [3]. - The lead candidate, AKTX-101, targets the Trop2 receptor on cancer cells and utilizes a proprietary linker to deliver the PH1 payload directly into tumors, minimizing off-target effects [3]. - PH1 is a spliceosome modulator designed to disrupt RNA splicing in cancer cells, showing potential to induce cancer cell death while activating both innate and adaptive immune responses [3]. - Preclinical studies indicate that AKTX-101 has significant activity and prolonged survival compared to traditional ADCs, with potential synergy when combined with checkpoint inhibitors [3]. - The company has initiated IND enabling studies for AKTX-101, aiming to start its First-In-Human trial by late 2026 or early 2027 [3]. - Akari is also developing AKTX-102, targeting CEACAM5, a tumor antigen expressed in various solid tumors, leveraging the PH1 payload for enhanced tumor cell killing and immune activation [3].

Core Viewpoint - Carrier Connect Data Solutions Inc. has announced an upsized private placement offering to raise up to $10,500,000 through the sale of units priced at $1.60 each [1][4]. Group 1: Offering Details - The offering will consist of up to 6,562,500 units, with each unit comprising one common share and one-half of a common share purchase warrant [1][2]. - Each warrant will be exercisable into one common share at an exercise price of $2.10 for a period of 24 months from the closing date [2]. Group 2: Regulatory Compliance - The units will be offered to purchasers in Canada under the listed issuer financing exemption and to investors in other jurisdictions, with no hold period applicable under Canadian securities laws [3]. Group 3: Use of Proceeds - The net proceeds from the offering are intended for acquisitions, debt repayment, capital improvements, data center expansions, marketing, staffing, and general corporate purposes [4]. Group 4: Closing and Regulatory Approvals - The offering is expected to close on or about February 26, 2026, subject to necessary regulatory approvals, including acceptance from the TSXV [6]. Group 5: Company Overview - Carrier Connect Data Solutions focuses on acquiring Tier II/III data centers internationally, providing co-location and data center solutions primarily to AI companies and small businesses [8]. - The company operates in key markets including Vancouver and Ottawa in Canada, and Perth in Australia [8].

Core Viewpoint - Sompo Holdings has received necessary regulatory approvals to acquire 100% of Aspen Insurance Holdings Limited, enhancing its insurance and reinsurance capabilities globally [1][2]. Group 1: Acquisition Details - The acquisition is expected to close in the next several days, pending customary closing conditions [2]. - Aspen's established insurance and reinsurance franchise, along with its top-tier Lloyd's syndicate, will provide Sompo with access to complex risks and untapped markets [2]. Group 2: Integration Plans - Following the acquisition, Sompo will integrate Aspen's capabilities to create a globally diversified Property & Casualty platform [3]. Group 3: Company Background - Sompo Group has over 137 years of experience in the insurance and financial services sector, focusing on health, wellbeing, and financial protection [4]. - The company operates globally in commercial and consumer property, casualty, specialty insurance, and reinsurance, as well as life insurance and nursing care in Japan [4]. Group 4: Financial Strength - Sompo's insurance subsidiaries hold strong financial ratings of A+ from both A.M. Best and Standard & Poor's, indicating robust financial strength [5].